| Metric | Q2 2026 | Q1 2026 | Q2 2025 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $369M | — | — | — | — |
| Op. Income | $17M | — | — | — | — |
| Gross Margin | 12.4% | — | — | — | — |
| Net Margin | 2.5% | — | — | — | — |
| EPS (Diluted) | $0.18 | — | — | — | — |
| Free Cash Flow | -$17M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $369M |
| Cost of Revenue | $323M |
| GROSS PROFIT | $46M |
| R&D Expenses | $0 |
| Selling & Marketing | $15M |
| General & Administrative | $13M |
| SG&A Expenses | $29M |
| Other Expenses | $0 |
| Operating Expenses | $29M |
| Cost & Expenses | $352M |
| OPERATING INCOME | $17M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $13M |
| Income Tax Expense | $4M |
| Net Income from Continuing Ops | $9M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $9M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $9M |
| D&A | $1M |
| EBIT | $17M |
| EBITDA | $18M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $369M |
| Cost of Revenue | $323M |
| GROSS PROFIT | $46M |
| R&D Expenses | $0 |
| Selling & Marketing | $15M |
| General & Administrative | $13M |
| SG&A Expenses | $29M |
| Other Expenses | $0 |
| Operating Expenses | $29M |
| Cost & Expenses | $352M |
| OPERATING INCOME | $17M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $13M |
| Income Tax Expense | $4M |
| Net Income from Continuing Ops | $9M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $9M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $9M |
| D&A | $1M |
| EBIT | $17M |
| EBITDA | $18M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $9M |
| Depreciation & Amortization | $1M |
| Stock-Based Compensation | $69.0K |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $4M |
| Change in Working Capital | -$32M |
| OPERATING CASH FLOW | -$17M |
| Capital Expenditure | -$367.0K |
| Acquisitions (Net) | -$1M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $40.0K |
| NET CASH FROM INVESTING | -$1M |
| Net Debt Issuance | $17M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$596.0K |
| NET CASH FROM FINANCING | $16M |
| FREE CASH FLOW | -$17M |
| Net Change in Cash | -$2M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1M |
| Short-Term Investments | $0 |
| Net Receivables | $159M |
| Inventory | $118M |
| Other Current Assets | $8M |
| TOTAL CURRENT ASSETS | $287M |
| PP&E (Net) | $29M |
| Goodwill | $94M |
| Intangible Assets | $20M |
| Long-Term Investments | $0 |
| Tax Assets | $4M |
| Other Non-Current Assets | $235.0K |
| TOTAL NON-CURRENT ASSETS | $147M |
| TOTAL ASSETS | $434M |
| Account Payables | $188M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $15M |
| TOTAL CURRENT LIABILITIES | $213M |
| Long-Term Debt | $85M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $3M |
| TOTAL NON-CURRENT LIABILITIES | $104M |
| TOTAL LIABILITIES | $316M |
| Common Stock | $5.0K |
| Additional Paid-In Capital | $49M |
| Retained Earnings | $69M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$76.0K |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $118M |
| Minority Interest | $0 |
| TOTAL EQUITY | $118M |
| TOTAL LIABILITIES & EQUITY | $434M |
| Total Debt | $107M |
| Net Debt | $106M |
